RxDoctor Payments Data

Carroll Christiansen, MD

Family Medicine · Spencer, WVNPI 1801898861

Payments from drug & device makers

$174in general payments, 2019–2025

Across 12 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$53
  • Philips North America LLC$33
  • Novo Nordisk$19
  • Novartis$17
  • Pfizer$15
  • Lilly USA, LLC$13
  • plus $25 from 2 others

What the payments were for

  • Food & beverage$174100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$174 in reported general payments places this provider in the 35th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$6,794
Medicare patients
244
Services billed
494

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide134$151,432
EliquisApixaban238$116,598
Humira PenAdalimumab14$94,978
XareltoRivaroxaban105$76,748
TrulicityDulaglutide32$48,876
JanuviaSitagliptin Phosphate109$45,094
EnbrelEtanercept12$44,244
EntrestoSacubitril/Valsartan57$31,044
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$30,132
JardianceEmpagliflozin42$26,599
MounjaroTirzepatide25$26,110
FarxigaDapagliflozin Propanediol22$20,403
LinzessLinaclotide33$18,240
RayaldeeCalcifediol12$13,729
Spiriva HandihalerTiotropium Bromide24$13,424

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$19$151,432134 claims
PfizerEliquis$15$116,598238 claims
Lilly USA, LLCTrulicity, Mounjaro$13$74,98557 claims
GSKTrelegy Ellipta, Arexvy$53$39,98466 claims
NovartisEntresto$17$31,04457 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Spencer

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →